The authors demonstrated that cancer cell lines resistant to ETC inhibition maintain their aspartate level high using the SLC1A3 transporter, and modulation of SLC1A3 notably changed the sensitivity of cancer cells to ETC suppression [30]. This evidence concerns the gene SLC1A3 and cancer.